An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Ania Cabrales et al.|New Biotechnology|2022Cited by 58
The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Glay Chinea-Santiago et al.|medRxiv|2021Cited by 19
CUBAN VACCINES ABDALA AND MAMBISA AGAINST COVID-19Gerardo Guillén, Estebán Martínez, Verena Muzio et al.|International Journal of Infectious Diseases|2023Cited by 7
HEPATITIS B NUCLEOCAPSID PARTICLE AS IMMUNOPOTENTIATOR OF INNATE AND ADAPTIVE IMMUNITY FOR NASAL VACCINES CIGB 2020 AND MAMBISA AGAINST COVID-19Gerardo Guillén, Estebán Martínez, Verena Muzio et al.|International Journal of Infectious Diseases|2023Cited by 0